Cardiac Surgery With Extracorporeal Circulation in Cancer Patients: Influence on Surgical Morbidity and Mortality, and on Survival

Carrascal, Yolanda; Gualis, Javier; Arévalo, Adolfo; Fulquet, Enrique; Flórez, Santiago; Rey, J.; Echevarría, José Ramón Llanes; Stefano, Salvatore Di; Fiz, Luis

doi:10.1016/s1885-5857(08)60137-1

Cited by 28 publications

(23 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The decision to offer cardiac surgery to patients with a history of malignancy will be influenced by the likely effect of the malignancy or the surgical outcome. However, there is conflicting information about the risks of heart surgery in patients with a history of malignancy, with some groups reporting little difference in the outcome [1][2][3], and others showing a significant impact on morbidity [4] and survival [5,6]. We therefore set out to assess the effect of malignancy on the outcome of cardiac surgery on our unit.…”

Section: Introductionmentioning

confidence: 99%

Cardiac Surgery in Patients with a History of Malignancy: Increased Complication Rate but Similar Mortality

Chan

Rosenfeldt

Chaudhuri

et al. 2012

Heart, Lung and Circulation

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Cardiac Surgery in Patients with a History of Malignancy: Increased Complication Rate but Similar Mortality

Chan

Rosenfeldt

Chaudhuri

et al. 2012

Heart, Lung and Circulation

View full text Add to dashboard Cite

“…In a trial performed on 89 cancer patients from different locations, the patients were operated under extracorporeal circulation; 45% had active cancer and were treated by SAVR [15]. Although perioperative morbidity and mortality were not different in cancer versus non-cancer patients, long-term survival was reduced in the active cancer subgroup because of cancer complications.…”

Section: Savr In Cancer Patientsmentioning

confidence: 99%

The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis?

et al. 2019

View full text Add to dashboard Cite

Purpose of Review Aging is associated with an increased prevalence of both cancer and heart disease. The progression of aortic valve calcification to aortic stenosis may be accelerated by both cardiovascular risk factors and cancer treatments, such as radiotherapy with mediastinal involvement. Symptomatic aortic stenosis is occasionally diagnosed in cancer patients undergoing cardiovascular evaluation; likewise, cancer is often recognized during assessment preceding aortic valve interventions. In these complex cases, physicians face difficult treatment decisions. Due to a myriad of clinical presentations of cancer and valve disease, specific guidelines for this patient population are not currently in place. Management is currently based on clinical judgment, on an individual basis. Recent Findings Patients with cancer in remission or with a favorable prognosis should be treated according to current cardiovascular guidelines. In these patients, aortic valve replacement can be performed either by surgery or transcatheter. Significant challenges arise in patients with active cancer, especially those receiving anti-cancer treatment. Recent data suggests that these patients can be offered aortic valve replacement, with a trend of favoring the transcatheter route in order to minimize perioperative This article is part of the Topical Collection on Cardio-Oncology

show abstract

“…Burada ana sorun tedavilerin endikasyonlarından daha çok kontrendikasyonlarıdır. Zira ayrı ayrı yapıldığı anda sorun yaratmayacak olan işlemlerin birlikte yapıldığın-da komplike olma ihtimali artmaktadır (16,17) …”

Section: Akci̇ğer Değerlendi̇rmesi̇unclassified

Sımultaneous Lung Cancer And Heart Dısease

Okay¹

2016

Toraks Cer Bult

View full text Add to dashboard Cite

Worldwide, especially in developed countries, prolonged life expectancy results in increasing number of age-related / associated diseases like diabetes mellitus, cardiovascular diseases, malignancies, neurological diseases, organ failures etc. in the community. Beside the numbers, planning and applying the treatment of pulmonary and cardiovascular diseases simultaneously in such patients is stil a major challenge. The knowledge and experience gained from the increasing number of patients all over the world led to the conclusion that it could be possible to treat some patient groups who would be considered as difficult or impossible to cure in the past. In this paper we evaluated the treatment process in lung diseases (especially malignancies) and cardiovascular disease seen simultaneously.Keywords: Lung cancer, heart disease, coronary artery disease, pulmonary surgery, concurrent heart lung disease, concurrent heart lung surgery ÖzetÖzellikle batıda olmak üzere tüm dünyada uzayan ortalama ömür süresi, yaşa bağlı/ilintili hastalıkların da toplumda daha sık görülmesi sonucunu doğurmaktadır. Bunlar diyabet, kalp damar hastalıkları, maligniteler, nörolojik hastalıklar, organ yetmezlikleri gibi hastalıklardır. Bu durumun yarattığı sorunlardan biri de eş zamanlı olarak görülen akciğer ve kalp damar hastalıklarının tedavisinin planlanması ve uygulanmasıdır. Tüm dünyada giderek artan sayıdaki hastalardan elde edilen bilgi ve deneyimler eskiden çok zor hatta imkansız olarak kabul edilen hasta gruplarında bile tedavi seçenekleri olabileceğini ve başarıyla uygulanabileceğini göstermektedir. Bu yazıda eş zamanlı görülen kalp-damar hastalıkları ve özel-likle maligniteler olmak üzere akciğer hastalıklarındaki tedavi süreçlerini değerlendirdik.Anahtar kelimeler: Akciğer kanseri, kalp hastalığı, koroner arter hastalığı, akciğer cerrahisi, eş zamanlı kalp akciğer hastalığı, eş zamanlı kalp akciğer cerrahisi

show abstract

Cardiac Surgery With Extracorporeal Circulation in Cancer Patients: Influence on Surgical Morbidity and Mortality, and on Survival

Cited by 28 publications

References 13 publications

Cardiac Surgery in Patients with a History of Malignancy: Increased Complication Rate but Similar Mortality

Cardiac Surgery in Patients with a History of Malignancy: Increased Complication Rate but Similar Mortality

The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis?

Sımultaneous Lung Cancer And Heart Dısease

Contact Info

Product

Resources

About